Novel Biomarker for Development of T2D

CompletedOBSERVATIONAL
Enrollment

202

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 5, 2023

Study Completion Date

April 5, 2023

Conditions
Diabetes Type II
Trial Locations (3)

27514

UNC Chapel Hill, Chapel Hill

27710

Duke University, Durham

70803

Pennington Biomedical Research center, Baton Rouge

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Children's Miracle Network

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Duke University

OTHER